Navigation Links
Neurologix Announces Second Quarter 2011 Financial Results
Date:8/11/2011

f operations after October 31, 2011 and to repay the promissory notes issued in December 2010 as of said date. Accordingly, there is substantial doubt as to the Company's ability to continue as a going concern. The Company is currently seeking to raise funds, through public or private equity offerings, debt financings or corporate collaboration and licensing arrangements, sufficient to finance its ongoing operations.  The Company does not know whether additional financing will be available when needed, or if available, will be on acceptable or favorable terms to it or its stockholders.
  • The Company will need to conduct future clinical trials for the treatment of Parkinson's disease using the Company's NLX technology. If the trials prove unsuccessful, future operations and the potential for profitability will be materially adversely affected and the business may not succeed.

  • Other factors and assumptions not identified above could also cause the actual results to differ materially from those set forth in the forward-looking statements. Additional information about factors that could cause results to differ materially from management's expectations is found in the section entitled "Risk Factors" in the Company's 2010 Annual Report on Form 10-K. Although the Company believes these assumptions are reasonable, no assurance can be given that they will prove correct. Accordingly, you should not rely upon forward-looking statements as a prediction of actual results. Further, the Company undertakes no obligation to update forward-looking statements after the date they are made or to conform the statements to actual results or changes in the Company's expectations.

    Contact:Neurologix
    Marc Panoff, 201-592-6451
    Chief Financial Officer
    marcpanoff@neurologix.net'/>"/>

    SOURCE Neurologix, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Neurologix Presents One-Year Follow-Up Data From Phase 2 Study of NLX-P101 in Parkinsons Disease at International Neuromodulation Society 10th World Congress
    2. Bion Announces New U.S. Patent for Phosphorus Removal
    3. ViaCyte Announces Executive Management Changes
    4. NeoStem Announces the Receipt of Over $1,700,000 in DOD Funding for its VSEL™ Technology Being Developed to Treat Osteoporosis
    5. Dendreon Announces Webcast Presentation at Canaccord Genuity Growth Conference
    6. Osteologix Announces Completion of Corporate Consolidation
    7. Interleukin Genetics, Inc. Announces Conference Call to Discuss Second Quarter 2011 Results
    8. Palatin Announces Commencement of a Phase 1 Trial for Obesity Compound in Collaboration with AstraZeneca
    9. Rigel Announces Second Quarter 2011 Financial Results
    10. WAVi Co. Announces Collaborative Agreement with SomaLogic, Inc.
    11. Vermillion Announces Notice of Allowance for Peripheral Artery Disease (PAD) Patent
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2014)... 29, 2014 /PRNewswire-iReach/ -- Nanosyn, Inc. announced today ... Inc., to provide access to Nanosyn,s microfluidics screening ... platform for novel small molecule therapeutics. ... to work with FORMA Therapeutics to explore key ... homeostasis. FORMA Therapeutics, decision to work with us ...
    (Date:7/29/2014)... , July 29, 2014  Cannabis Science, Inc. ... formulation-based drug development and related consulting, applauds the ... taking a strong position in opposition to current ... 27, 2014 publication.  The New York Times also ... this week exploring the issue called "High Time:  ...
    (Date:7/29/2014)... TransVac Solutions, the trusted leader in ... solutions for hospitals, will be exhibiting at booth #209 ... Conference & Technical Exhibition Aug. 3-6 in Chicago, Ill. ... making hospitals cleaner, reducing infection risk and saving millions ... cycle. Staff will be available at booth #209 ...
    (Date:7/29/2014)... (PRWEB) July 29, 2014 Philadelphia’s newest entrepreneurial ... businesses get their start. The Innovation Center @3401 , ... University City Science Center to help attract and ... on Monday, July 28. , The Innovation ... 34th and Market Streets, is the new home of ...
    Breaking Biology Technology:Nanosyn Announces Expanded Partnership With FORMA Therapeutics 2Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change 2Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change 3TransVac Presents Cost Saving Technology at ASHE Conference for Keeping Hospitals Cleaner 2Innovation Center @3401 Opens for Business; DreamIt Ventures and Point.io First Residents 2Innovation Center @3401 Opens for Business; DreamIt Ventures and Point.io First Residents 3
    ... the world,s most powerful supercomputers, scientists at Lawrence ... are a good match for the future development ... potential for green energy production because of their ... performed on "Franklin," a Cray XT4 massively parallel ...
    ... ... Produce Fuels Directly from Cellulosic Biomass , ... South San Francisco, CA (PRWEB) January 27, 2010 -- ... ability to make cellulosic-derived advanced biofuels. A collaborative team of researchers from LS9, ...
    ... ... Sudek , Chairman of Tech Coast Angels (TCA), the nation,s ... 2010 program of increased entrepreneur support, communication and mentoring will be overseen ... today,s constrained economy, entrepreneurs need easier access to viable sources of help ...
    Cached Biology Technology:Mismatched alloys are a good match for thermoelectrics 2Mismatched alloys are a good match for thermoelectrics 3LS9, Inc., U.C Berkeley, and JBEI Make Major Breakthrough in Cellulosic Fuels Production 2LS9, Inc., U.C Berkeley, and JBEI Make Major Breakthrough in Cellulosic Fuels Production 3LS9, Inc., U.C Berkeley, and JBEI Make Major Breakthrough in Cellulosic Fuels Production 4Sudek of Tech Coast Angels Announces Network's Increased Commitment to Entrepreneurship and Innovation Through New Easy-Access Programs 2Sudek of Tech Coast Angels Announces Network's Increased Commitment to Entrepreneurship and Innovation Through New Easy-Access Programs 3Sudek of Tech Coast Angels Announces Network's Increased Commitment to Entrepreneurship and Innovation Through New Easy-Access Programs 4
    (Date:7/28/2014)... Eight of the top 10 U.S. cities that have ... public inconveniences as frequent road closures, overwhelmed storm drains ... a new NOAA technical report. , This nuisance flooding, ... three U.S. coasts, between 300 and 925 percent since ... Nuisance Flood Frequency Changes around the United States, also ...
    (Date:7/28/2014)... identified areas of the Earth that are high priorities ... Europe is particularly vulnerable, as it has the lowest ... of any continent in ,refugia, areas of biological ... remain relatively constant during times of great environmental change. ... in Scandinavia and Scotland. , The biggest refugia ...
    (Date:7/28/2014)... researchers are using magnetic beads and DNA "springs" to ... as microscale models for polymer macromolecules. , The experiment ... in the 1950s, can be made as stiff or ... to materials scientists who study the basic physics of ... biomolecular engineer Sibani Lisa Biswal and graduate student Julie ...
    Breaking Biology News(10 mins):NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 2NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 3Study finds Europe's habitat and wildlife is vulnerable to climate change 2Seeing is bead-lieving 2
    ... 2012) Immune system abnormalities that mimic those seen with ... protein (APP), reports a research team from the University of ... Center. The study, conducted with mouse models of ... in the blood could explain the aberrations in immune cell ...
    ... too quickly seemed to have sipped from the fountain of ... Medicine injected them with stem cell-like progenitor cells derived from ... and dying early as untreated mice did, animals that got ... three times longer than expected, according to findings published in ...
    ... pancreatitis and pancreatic cancer is to be explored further ... the Medical Research Council (MRC). Pancreatitis can develop ... pancreas itself. Chronic pancreatitis increases the risk of pancreatic ... all common cancers in the UK. High alcohol intake ...
    Cached Biology News:Autism may be linked to abnormal immune system characteristics and novel protein fragment 2Pitt: A shot of young stem cells made rapidly aging mice live longer and healthier 2New stage in fighting pancreatic cancer 2
    ...
    ... Fixed clamp trays ... easy Magnetic drive ... rpm 25 mm amplitude ... 25 ml to 2000 ml, including ...
    ... rapid, convenient, and efficient Denatured protein concentration ... a spin column to make handling easy. ... proteins which were electro-eluted in their Denatured ... offering high binding capacity fo all pH ...
    In Western blotting antibodies recognize 94 K protein band, which corresponds to S-layer protein...
    Biology Products: